Furthermore, we found that synergic use of anti-DNAM-1 and anti-NKG2D antibodies decreased the cytolytic ability of CIK cells obtained from HCC patients, suggesting that CIK cells may display cytotoxicity in a DNAM-1 and NKG2D-dependent manner (S4 Fig). This evidence concerns the gene CD226 and hepatocellular carcinoma.